HomeOLMA • NASDAQ
add
Olema Pharmaceuticals Inc
Previous close
$10.71
Day range
$9.78 - $10.76
Year range
$3.64 - $17.79
Market cap
553.56M USD
Avg Volume
948.46K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 30.42M | 11.75% |
Net income | -26.77M | -2.27% |
Net profit margin | — | — |
Earnings per share | -0.49 | 24.62% |
EBITDA | -30.33M | -11.82% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 261.81M | 28.07% |
Total assets | 276.94M | 28.43% |
Total liabilities | 23.05M | 27.36% |
Total equity | 253.90M | — |
Shares outstanding | 55.91M | — |
Price to book | 2.32 | — |
Return on assets | -26.69% | — |
Return on capital | -28.48% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -26.77M | -2.27% |
Cash from operations | -18.48M | 6.27% |
Cash from investing | -30.92M | -289.24% |
Cash from financing | 523.00K | 91.58% |
Net change in cash | -48.87M | -1,475.37% |
Free cash flow | -8.58M | 15.73% |
About
Founded
2006
Headquarters
Website
Employees
74